TY - CHAP AU - Hall, C. B. AU - Hall, W. J. ED - Mandell, G. L. ED - Bennett, J. E. ED - Dolin, R. PY - 1995 DA - 1995// TI - Bronchiolitis BT - Principles and Practice of Infectious Diseases PB - Churchill Livingstone CY - New York ID - Hall1995 ER - TY - JOUR AU - Glezen, W. P. AU - Taber, L. H. AU - Frank, A. L. AU - Kasel, J. A. PY - 1986 DA - 1986// TI - Risk of primary infection and reinfection with respiratory syncytial virus JO - Am J Dis Child (1960) VL - 140 ID - Glezen1986 ER - TY - JOUR AU - Paramore, L. C. AU - Ciuryla, V. AU - Ciesla, G. AU - Liu, L. PY - 2004 DA - 2004// TI - Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases JO - Pharmacoeconomics VL - 22 UR - https://doi.org/10.2165/00019053-200422050-00001 DO - 10.2165/00019053-200422050-00001 ID - Paramore2004 ER - TY - JOUR AU - Groothuis, J. R. AU - Gutierrez, K. M. AU - Lauer, B. A. PY - 1988 DA - 1988// TI - Respiratory syncytial virus infection in children with bronchopulmonary dysplasia JO - Pediatrics VL - 82 ID - Groothuis1988 ER - TY - JOUR AU - Heilman, C. A. PY - 1990 DA - 1990// TI - From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses JO - J Infect Dis VL - 161 UR - https://doi.org/10.1093/infdis/161.3.402 DO - 10.1093/infdis/161.3.402 ID - Heilman1990 ER - TY - JOUR AU - MacDonald, N. E. AU - Hall, C. B. AU - Suffin, S. C. AU - Alexson, C. AU - Harris, P. J. AU - Manning, J. A. PY - 1982 DA - 1982// TI - Respiratory syncytial viral infection in infants with congenital heart disease JO - N Engl J Med VL - 307 UR - https://doi.org/10.1056/NEJM198208123070702 DO - 10.1056/NEJM198208123070702 ID - MacDonald1982 ER - TY - JOUR PY - 2009 DA - 2009// TI - Policy statement--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections JO - Pediatrics VL - 124 UR - https://doi.org/10.1542/peds.2009-1807 DO - 10.1542/peds.2009-1807 ID - ref7 ER - TY - CHAP PY - 2008 DA - 2008// BT - Synagis® (palivizumab) package insert ID - ref8 ER - TY - JOUR AU - Johnson, S. AU - Oliver, C. AU - Prince, G. A. AU - Hemming, V. G. AU - Pfarr, D. S. AU - Wang, S. C. AU - Dormitzer, M. AU - O'Grady, J. AU - Koenig, S. AU - Tamura, J. K. AU - Woods, R. AU - Bansal, G. AU - Couchenour, D. AU - Tsao, E. AU - Hall, W. C. AU - Young, J. F. PY - 1997 DA - 1997// TI - Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus JO - J Infect Dis VL - 176 UR - https://doi.org/10.1086/514115 DO - 10.1086/514115 ID - Johnson1997 ER - TY - JOUR AU - Feltes, T. F. AU - Cabalka, A. K. AU - Meissner, H. C. AU - Piazza, F. M. AU - Carlin, D. A. AU - Top, F. H. AU - Connor, E. M. AU - Sondheimer, H. M. PY - 2003 DA - 2003// TI - Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease JO - J Pediatrics VL - 143 UR - https://doi.org/10.1067/S0022-3476(03)00454-2 DO - 10.1067/S0022-3476(03)00454-2 ID - Feltes2003 ER - TY - JOUR AU - Pedraz, C. AU - Carbonell-Estrany, X. AU - Figueras-Aloy, J. AU - Quero, J. PY - 2003 DA - 2003// TI - Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants JO - Pediatr Infect Dis J VL - 22 UR - https://doi.org/10.1097/01.inf.0000086403.50417.7c DO - 10.1097/01.inf.0000086403.50417.7c ID - Pedraz2003 ER - TY - JOUR PY - 1998 DA - 1998// TI - Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group JO - Pediatrics VL - 102 UR - https://doi.org/10.1542/peds.102.3.531 DO - 10.1542/peds.102.3.531 ID - ref12 ER - TY - JOUR AU - Mejias, A. AU - Chávez-Bueno, S. AU - Ríos, A. M. AU - Aten, M. F. AU - Raynor, B. AU - Peromingo, E. AU - Soni, P. AU - Olsen, K. D. AU - Kiener, P. A. AU - Gómez, A. M. AU - Jafri, H. S. AU - Ramilo, O. PY - 2005 DA - 2005// TI - Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.11.4700-4707.2005 DO - 10.1128/AAC.49.11.4700-4707.2005 ID - Mejias2005 ER - TY - JOUR AU - Wu, H. AU - Pfarr, D. S. AU - Tang, Y. AU - An, L. L. AU - Patel, N. K. AU - Watkins, J. D. AU - Huse, W. D. AU - Kiener, P. A. AU - Young, J. F. PY - 2005 DA - 2005// TI - Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization JO - J Mol Biol VL - 350 UR - https://doi.org/10.1016/j.jmb.2005.04.049 DO - 10.1016/j.jmb.2005.04.049 ID - Wu2005 ER - TY - JOUR AU - Wu, H. AU - Pfarr, D. S. AU - Johnson, S. AU - Brewah, Y. A. AU - Woods, R. M. AU - Patel, N. K. AU - White, W. I. AU - Young, J. F. AU - Kiener, P. A. PY - 2007 DA - 2007// TI - Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract JO - J Mol Biol VL - 368 UR - https://doi.org/10.1016/j.jmb.2007.02.024 DO - 10.1016/j.jmb.2007.02.024 ID - Wu2007 ER - TY - JOUR AU - Mejias, A. AU - Chavez-Bueno, S. AU - Raynor, M. B. AU - Connolly, J. AU - Kiener, P. A. AU - Jafri, H. S. AU - Ramilo, O. PY - 2007 DA - 2007// TI - Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model JO - Virol J VL - 4 UR - https://doi.org/10.1186/1743-422X-4-109 DO - 10.1186/1743-422X-4-109 ID - Mejias2007 ER - TY - JOUR AU - Abarca, K. AU - Jung, E. AU - Fernandez, P. AU - Zhao, L. AU - Harris, B. AU - Connor, E. M. AU - Losonsky, G. A. PY - 2009 DA - 2009// TI - Safety, tolerability, pharmacokinetics, and immunogenicity of motavizumab, a humanized, enhanced-potency monoclonal antibody for the prevention of respiratory syncytial virus infection in at-risk children JO - Pediatr Infect Dis J VL - 28 UR - https://doi.org/10.1097/INF.0b013e31818ffd03 DO - 10.1097/INF.0b013e31818ffd03 ID - Abarca2009 ER - TY - JOUR AU - Lagos, R. AU - Devincenzo, J. P. AU - Munoz, A. AU - Hultquist, M. AU - Suzich, J. AU - Connor, E. M. AU - Losonsky, G. A. PY - 2009 DA - 2009// TI - Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children JO - Pediatr Infect Dis J VL - 28 UR - https://doi.org/10.1097/INF.0b013e3181a165e4 DO - 10.1097/INF.0b013e3181a165e4 ID - Lagos2009 ER - TY - JOUR AU - Malley, R. AU - DeVincenzo, J. AU - Ramilo, O. AU - Dennehy, P. H. AU - Meissner, H. C. AU - Gruber, W. C. AU - Sanchez, P. J. AU - Jafri, H. AU - Balsley, J. AU - Carlin, D. AU - Buckingham, S. AU - Vernacchio, L. AU - Ambrosino, D. M. PY - 1998 DA - 1998// TI - Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein JO - J Infect Dis VL - 178 UR - https://doi.org/10.1086/314523 DO - 10.1086/314523 ID - Malley1998 ER - TY - JOUR AU - Carbonell-Estrany, X. AU - Simões, E. A. F. AU - Dagan, R. AU - Hall, C. B. AU - Harris, B. AU - Hultquist, M. AU - Connor, E. M. AU - Losonsky, G. A. PY - 2010 DA - 2010// TI - Motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in high-risk children: A randomized controlled noninferiority trial JO - Pediatrics VL - 125 UR - https://doi.org/10.1542/peds.2008-1036 DO - 10.1542/peds.2008-1036 ID - Carbonell-Estrany2010 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/10/38/prepub UR - http://www.biomedcentral.com/1471-2431/10/38/prepub ID - ref21 ER -